Company / Operating Cash Flow per Share
Kura Oncology, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.82
FY2025
5-year range
-$1.70 / $1.81
FY2021-FY2025
Trend
-145.3%
vs FY2024
Sector context
#109 of 212
Health Care
What the data says
At $-0.82, Kura Oncology, Inc.'s operating cash flow per share ranks #109 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-1.70 in FY2023 to $1.81 in FY2024.
Based on SEC 10-K filings.
-0.82 in FY2025.
Improved from $-1.70 to $-0.82 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 212 in Health CareTop 51% of 212This company -$0.82 Sector average -$14.72
▼
+94.4% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 145.3% year-over-year.
- Ranks #109 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.82 | -145.3% |
| FY2024 | $1.81 | +206.0% |
| FY2023 | -$1.70 | -3.7% |
| FY2022 | -$1.64 | -4.3% |
| FY2021 | -$1.58 | -19.8% |
| FY2020 | -$1.32 | -0.8% |
| FY2019 | -$1.31 | +5.6% |
| FY2018 | -$1.38 | -13.0% |
| FY2017 | -$1.22 | +9.7% |
| FY2016 | -$1.36 | +24.9% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026